NO983451L - FremgangsmÕte for hemming av colontumorer - Google Patents
FremgangsmÕte for hemming av colontumorerInfo
- Publication number
- NO983451L NO983451L NO983451A NO983451A NO983451L NO 983451 L NO983451 L NO 983451L NO 983451 A NO983451 A NO 983451A NO 983451 A NO983451 A NO 983451A NO 983451 L NO983451 L NO 983451L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- inhibiting colon
- colon tumors
- inhibiting
- rog
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Abstract
Fremgangsmåte for hemming av coloncancer omfatter administrering til et pattedyr som har behov for dette av en effektiv mengde av en forbindelse som har formel (I),. der Rog Ruavhengig av hverandre er hydrogen, -CH, (a), eller (b), hvori Ar eventuelt er substituert fenyl; RJ blir valgt fra gruppen bestående av pyrrolidin, heksametylenimin og piperidin; eller et farmasøytisk akseptabelt salt eller solvat derav.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1077296P | 1996-01-29 | 1996-01-29 | |
GBGB9603150.5A GB9603150D0 (en) | 1996-02-15 | 1996-02-15 | Methods of inhibiting colon tumors |
PCT/US1997/002286 WO1997026877A1 (en) | 1996-01-29 | 1997-01-27 | Methods of inhibiting colon tumors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO983451L true NO983451L (no) | 1998-07-27 |
NO983451D0 NO983451D0 (no) | 1998-07-27 |
Family
ID=26308709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983451A NO983451D0 (no) | 1996-01-29 | 1998-07-27 | FremgangsmÕte for hemming av colontumorer |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0921799A4 (no) |
JP (1) | JP2000503994A (no) |
KR (1) | KR19990082054A (no) |
CN (1) | CN1209745A (no) |
AR (1) | AR010978A1 (no) |
AU (1) | AU707892B2 (no) |
BR (1) | BR9700778A (no) |
CO (1) | CO4761062A1 (no) |
CZ (1) | CZ235498A3 (no) |
EA (1) | EA001104B1 (no) |
ID (1) | ID15917A (no) |
IL (1) | IL125521A (no) |
MX (1) | MX9806036A (no) |
NO (1) | NO983451D0 (no) |
NZ (1) | NZ331105A (no) |
PL (1) | PL328147A1 (no) |
TW (1) | TW446560B (no) |
WO (1) | WO1997026877A1 (no) |
YU (1) | YU2397A (no) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
JPH07149638A (ja) * | 1993-10-15 | 1995-06-13 | Eli Lilly & Co | 耐性新生物の治療法 |
US5574047A (en) * | 1993-12-21 | 1996-11-12 | Eli Lilly And Company | Methods of inhibiting imperfect tissue repair |
-
1997
- 1997-01-22 ID IDP970182A patent/ID15917A/id unknown
- 1997-01-24 YU YU2397A patent/YU2397A/sr unknown
- 1997-01-24 AR ARP970100300A patent/AR010978A1/es unknown
- 1997-01-25 TW TW086100832A patent/TW446560B/zh not_active IP Right Cessation
- 1997-01-27 NZ NZ331105A patent/NZ331105A/en unknown
- 1997-01-27 CN CN97191791A patent/CN1209745A/zh active Pending
- 1997-01-27 JP JP9527132A patent/JP2000503994A/ja active Pending
- 1997-01-27 BR BR9700778A patent/BR9700778A/pt active Search and Examination
- 1997-01-27 KR KR1019980705775A patent/KR19990082054A/ko not_active Application Discontinuation
- 1997-01-27 CZ CZ982354A patent/CZ235498A3/cs unknown
- 1997-01-27 AU AU21239/97A patent/AU707892B2/en not_active Ceased
- 1997-01-27 EA EA199800677A patent/EA001104B1/ru not_active IP Right Cessation
- 1997-01-27 EP EP97906587A patent/EP0921799A4/en not_active Withdrawn
- 1997-01-27 IL IL12552197A patent/IL125521A/en not_active IP Right Cessation
- 1997-01-27 PL PL97328147A patent/PL328147A1/xx unknown
- 1997-01-27 WO PCT/US1997/002286 patent/WO1997026877A1/en not_active Application Discontinuation
- 1997-01-28 CO CO97003856A patent/CO4761062A1/es unknown
-
1998
- 1998-07-27 MX MX9806036A patent/MX9806036A/es unknown
- 1998-07-27 NO NO983451A patent/NO983451D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU707892B2 (en) | 1999-07-22 |
EA001104B1 (ru) | 2000-10-30 |
KR19990082054A (ko) | 1999-11-15 |
ID15917A (id) | 1997-08-21 |
YU2397A (en) | 1999-11-22 |
MX9806036A (es) | 1998-11-29 |
BR9700778A (pt) | 1998-10-06 |
EP0921799A1 (en) | 1999-06-16 |
TW446560B (en) | 2001-07-21 |
PL328147A1 (en) | 1999-01-18 |
AR010978A1 (es) | 2000-08-02 |
CN1209745A (zh) | 1999-03-03 |
IL125521A0 (en) | 1999-03-12 |
JP2000503994A (ja) | 2000-04-04 |
WO1997026877A1 (en) | 1997-07-31 |
EA199800677A1 (ru) | 1999-02-25 |
AU2123997A (en) | 1997-08-20 |
NZ331105A (en) | 2000-06-23 |
CZ235498A3 (cs) | 1999-02-17 |
NO983451D0 (no) | 1998-07-27 |
IL125521A (en) | 2001-11-25 |
EP0921799A4 (en) | 2002-03-13 |
CO4761062A1 (es) | 1999-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO944928L (no) | Fremgangsmåter for inhibering av Alzheimers sykdom | |
EA200100766A1 (ru) | Хинолин-2-он замещенные гетероарильные производные, используемые в качестве противоопухолевых агентов | |
MY116915A (en) | Substituted indazole analogs | |
NO20062617L (no) | Anvendelse av glukosidase inhibitorer for terapi av mucovisidose | |
NO971520L (no) | Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y | |
NO20055143L (no) | Doseringsformer innbefattende AG013736 | |
NO944927L (no) | Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom | |
RU94045846A (ru) | Применение производных бензотиофена для ингибирования тромбина | |
DK0659417T3 (da) | Fremgangsmåder til inhibering af dysfunktionel blødning fra livmoderen | |
NO944926L (no) | Fremgangsmåter for å inhibere myeloperoksidaseaktivitet | |
HUP0302961A2 (hu) | (Aminoalkoxibenzoil) benzofuránok vagy benzotiofének, eljárás ilyen vegyületek előállítására és ilyen vegyületeket tartalmazó készítmények | |
NO975580L (no) | Fremgangsmåte for å inhibere melanom | |
NO20010654D0 (no) | Ny anvendelse av taxoidderivater | |
NO944924L (no) | Fremgangsmåter for inhibering av Turner's syndrom | |
NO973367L (no) | Fremgangsmåte for å inhibere miljömessige östrogen | |
NO970786L (no) | Fremgangsmåte for hemming av benprotesedegradering | |
NO975738L (no) | Modulering av kalsiumkanaler | |
NO981578L (no) | FremgangsmÕte for hemming av plasminogenaktivatorhemmer I | |
NO983451L (no) | FremgangsmÕte for hemming av colontumorer | |
NO970783L (no) | Fremgangsmåte for å hindre endometrialkreft | |
NO973609L (no) | Fremgangsmåte for å inhibere effektene av IL-6 | |
NO983452L (no) | FremgangsmÕter for Õ hemme muskuloaponeurotisk fibromatose (desmoide tumorer) | |
NO971794L (no) | Fremgangsmåte for hemming av tilstander forbundet med bradykinin | |
NO971029L (no) | Fremgangsmåter for hemming av endometriale metoser | |
MX9701333A (es) | Metodos para inhibir el daño neuronal. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |